Is there any progress in the treatment of non-alcoholic fatty liver disease?

被引：5

作者：

Emmanuel A Tsochatzis ^{[1
]}

George V Papatheodoridis ^{[1
]}

机构：

[1] 2nd Department of Internal Medicine,Athens University Medical School,Hippokration General Hospital

来源：

World Journal of Gastrointestinal Pharmacology and Therapeutics | 2011年 / 01期

关键词：

Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Weight loss; Pioglitazone; Metformin;

D O I：

暂无

中图分类号：

R575.5 [肝代谢障碍];

学科分类号：

1002 ; 100201 ;

摘要：

Despite the fact that non-alcoholic fatty liver disease(NAFLD) and its severe clinical form,non-alcoholic steatohepatitis,are becoming increasingly prevalent in the industrialised countries,there are no licensed pharmacological treatments for them.Weight loss and life modifications,antioxidant therapies and insulin-sensitising agents are the current treatment strategies and have all been tested with inconclusive results.Low sample numbers,inadequate treatment duration and invalid surrogate markers for treatment response might all account for these results.As NAFLD is a systemic rather than a liver disease,future trials should address the patient as a whole and also address cardiovascular risk factors.

引用

页码：1 / 5

页数：5

共 26 条

[1]

Emerging Molecular Targets for the Treatment of Nonalcoholic Fatty Liver Disease[J] . Giovanni Musso,Roberto Gambino,Maurizio Cassader.Annual Review of Medicine . 2010

[2]

Long‐term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy （FLIRT 2） extension trial[J] . Vlad Ratziu,Fréderic Charlotte,Carole Bernhardt,Philippe Giral,Marine Halbron,Gilles LeNaour,Agnès Hartmann‐Heurtier,Eric Bruckert,Thierry Poynard.Hepatology . 2010 (2)

[3]

Long‐term mortality in nonalcoholic fatty liver disease: Is liver histology of any prognostic significance?[J] . Paul Angulo.Hepatology . 2010 (2)

[4]

Atorvastatin decreases serum levels of advanced glycation endproducts （AGEs） in nonalcoholic steatohepatitis （NASH） patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH[J] . Yuki Kimura,Hideyuki Hyogo,Sho-ichi Yamagishi,Masayoshi Takeuchi,Tomokazu Ishitobi,Yoshitaka Nabeshima,Koji Arihiro,Kazuaki Chayama.Journal of Gastroenterology . 2010 (7)

[5]

Insulin resistance and metabolic syndrome in chronic liver diseases: Old entities with new implications[J] . Emmanuel A. Tsochatzis,Spilios Manolakopoulos,George V. Papatheodoridis,Athanasios J. Archimandritis.Scandinavian Journal of Gastroenterology . 2009 (1)

[6]

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy （FLIRT） Trial[J] . Vlad Ratziu,Philippe Giral,Sophie Jacqueminet,Fréderic Charlotte,Agnès Hartemann–Heurtier,Lawrence Serfaty,Philippe Podevin,Jean–Marc Lacorte,Carole Bernhardt,Eric Bruckert,André Grimaldi,Thierry Poynard.Gastroenterology . 2008 (1)

[7] Fructose consumption as a risk factor for non-alcoholic fatty liver disease [J].

Ouyang, Xiaosen ;

Cirillo, Pietro ;

Sautin, Yuri ;

McCall, Shannon ;

Bruchette, James L. ;

Diehl, Anna Mae ;

Johnson, Richard J. ;

Abdelmalek, Manal F. .

JOURNAL OF HEPATOLOGY, 2008, 48 (06) :993-999

[8] Hepatology may have problems with putative surrogate outcome measures [J].

Gluud, Christian ;

Brok, Jesper ;

Gong, Yan ;

Koretz, Ronald L. .

JOURNAL OF HEPATOLOGY, 2007, 46 (04) :734-742

[9] Nonalcoholic steatohepatitis in donors for living donor liver transplantation [J].

Yamamoto, Koji ;

Takada, Yasutsugu ;

Fujimoto, Yasuhiro ;

Haga, Hironori ;

Oike, Fumitaka ;

Kobayashi, Nobuaki ;

Tanaka, Koichi .

TRANSPLANTATION, 2007, 83 (03) :257-262

[10]

High prevalence of elevated liver enzymes in blood donors: associations with male gender and central adiposity[J] . George V. Papatheodoridis,John Goulis,Dimitrios Christodoulou,Spilios Manolakopoulos,Maria Raptopoulou,Evangelia Andrioti,Nikolaos Alexandropoulos,Savoula Savvidou,Aikaterini Papachristou,Eleftheria Zervou,Kostas Seferiadis,Polyxeni Kousidou,Evangelos Vogiatzakis,Epaminondas Tsianos.European Journal of Gastroenterology ＆ Hepatology . 2007 (4)

← 1 2 3 →